{"id":"clm_BAC94969E9C8","entity":"eli-lilly","predicate":"total_equity","value":"15,764,800,000 United States dollar","value_json":{"fp":"Q1","fy":2025,"accn":"0000059478-25-000132","form":"10-Q","filed":"2025-05-01","period":"Q1 FY2025","concept":"us-gaap:StockholdersEquity"},"valid_from":"2025-03-31","valid_to":"2025-06-30","published":"2025-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Eli Lilly and Company total equity: 15,764,800,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_BAC94969E9C8, https://asof.is/claim/clm_BAC94969E9C8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/59478/000005947825000132/0000059478-25-000132-index.htm.","url":"https://asof.is/claim/clm_BAC94969E9C8","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_8BC2286999EC","supersedes":["clm_3C3D7729DB02"],"first_seen_at":"2026-11-08T15:32:10.500298+00:00","updated_at":"2026-11-08T15:32:18.231201+00:00","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947825000132/0000059478-25-000132-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2025","published_at":"2025-05-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2025, filed 2025-05-01"},"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}